Allogenic bone marrow transplantation with fludarabine/busulfan16 conditioning regimen and dasatinib maintenance therapy for elderly Philadelphia-positive acute/advanced leukemia patients

Leuk Res. 2010 Apr;34(4):e111-2. doi: 10.1016/j.leukres.2009.09.027. Epub 2009 Oct 13.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Disease
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Bone Marrow Transplantation*
  • Busulfan / administration & dosage*
  • Chemotherapy, Adjuvant
  • Dasatinib
  • Humans
  • Immunosuppressive Agents / administration & dosage
  • Leukemia / genetics
  • Leukemia / therapy*
  • Male
  • Philadelphia Chromosome
  • Pyrimidines / administration & dosage*
  • Thiazoles / administration & dosage*
  • Transplantation Conditioning* / methods
  • Transplantation, Homologous
  • Vidarabine / administration & dosage
  • Vidarabine / analogs & derivatives*

Substances

  • Immunosuppressive Agents
  • Pyrimidines
  • Thiazoles
  • Vidarabine
  • Busulfan
  • fludarabine
  • Dasatinib